Article
Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
Kidney international - 1 Apr 2017
Oh Chang Joo, Ha Chae-Myeong, Choi Young-Keun, Park Sungmi, Choe Mi Sun, Jeoung Nam Ho, Huh Yang Hoon, Kim Hyo-Jeong, Kweon Hee-Seok, Lee Ji-Min, Lee Sun Joo, Jeon Jae-Han, Harris Robert A, Park Keun-Gyu, Lee In-Kyu
Abstract excerpt
Clinical prescription of cisplatin, one of the most widely used chemotherapeutic agents, is limited by its side effects, particularly tubular injury-associated nephrotoxicity. Since details of the underlying mechanisms are not fully understood, we investigated the role of pyruvate dehydrogenase kinase (PDK) in cisplatin-induced acute kidney injury. Among the PDK isoforms, PDK4 mRNA and protein levels were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
